Krystal Biotech, Inc. ( KRYS) - Key Metrics

KRYS Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $4.04 $1.85 $2.53 $2.41
2026Q1 $3.97 $1.91 $2.74 $2.50
2025Q4 $3.70 $1.78 $2.68 $2.60
2025Q3 $3.38 $2.74 $1.37 $1.31
2025Q2 $3.32 $1.33 $1.82 $1.76

KRYS Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 50.23
2026Q1 0% 33.81
2025Q4 0% 34.82
2025Q3 0% 16.11
2025Q2 0% 25.84

KRYS Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.65% 0%
2026Q1 0.97% 0%
2025Q4 1.06% 0%
2025Q3 0.74% 0%
2025Q2 1.28% 0%

KRYS

Price: $332.27

52 week price:
131.00
382.54

Earnings Per Share: 7.97 USD

P/E Ratio: 40.96

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 151900

Ebitda: -2.1 million

Market Capitalization: 9.7 billion

Links: